Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review
Claudia Altamura,1,2 Nicoletta Brunelli,1,2 Marilena Marcosano,1,2 Alessandro Alesina,1,2 Luisa Fofi,1,2 Fabrizio Vernieri1,2 1Fondazione Policlinico Universitario Campus Bio-Medico, Roma, 00128, Italy; 2Unit of Headache and Neurosonology, Department of Medicine and Surgery, Università Campus Bio-Me...
Saved in:
Main Authors: | Altamura C (Author), Brunelli N (Author), Marcosano M (Author), Alesina A (Author), Fofi L (Author), Vernieri F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extended regular use of kinetic oscillation stimulation (KOS) in refractory chronic migraine: case report of a first, single-subject experience
by: Giorgio Liaci, et al.
Published: (2024) -
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab
by: Damiana Scuteri, et al.
Published: (2021) -
Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine
by: Brian Baker, et al.
Published: (2020) -
Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
by: Brian Baker, et al.
Published: (2022) -
Corrigendum to "Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies"
Published: (2024)